MACROmol Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
MACROmol General Information
Description
Developer of a polymeric platform intended to treat tuberculosis. The company's polymeric platform offers a multi-medicine system for nanomedicine innovation to maximize the clinical impact of therapeutics, enabling patients to have fewer drug regimens with improved results.
Contact Information
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
- Cambridge
- England, United Kingdom
MACROmol Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Accelerator/Incubator | 01-Apr-2015 | Completed | Startup |
MACROmol Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Accelerate Cambridge | Accelerator/Incubator | 000 0000 | 000000 0 |